Drug recall · August 23, 2017
Procrit Epoetin Alfa 40 recall
Why: Presence of particulate matter: Visible glass flakes identified as lamellae in some drug product vials.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Procrit Epoetin Alfa 40,000 units/mL single use vial For Intravenouse or Subcutaneous Use Only, Rx only, Manufactured by: Amgen Inc., Thousand Oaks, CA 91320-1799, Manufactured for: Janssen Products, LP Horsham, PA 19044, NDC 59676-340-01
- Lots / codes
Lot #: G290491A, G290491B, Exp. 06/18
- Quantity
- 175,632 vials
- Company
- Amgen, Inc., Thousand Oaks, CA
- Distribution
- United States including Puerto Rico
- Initiated
- August 4, 2017 · Voluntary: Firm initiated
- Classified
- August 14, 2017
- Reported
- August 23, 2017
- Ended
- March 29, 2018
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Procrit
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.